Legal & General Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-43,044
Closed -$2.53M 3402
2023
Q4
$2.53M Sell
43,044
-3,941
-8% -$232K ﹤0.01% 1828
2023
Q3
$2.05M Buy
46,985
+7,994
+21% +$348K ﹤0.01% 1894
2023
Q2
$1.41M Sell
38,991
-1,244
-3% -$44.9K ﹤0.01% 2077
2023
Q1
$1.5M Buy
40,235
+5,076
+14% +$189K ﹤0.01% 2008
2022
Q4
$1.59M Sell
35,159
-1,096
-3% -$49.7K ﹤0.01% 1976
2022
Q3
$2.53M Sell
36,255
-2,142
-6% -$150K ﹤0.01% 1742
2022
Q2
$2.58M Sell
38,397
-294
-0.8% -$19.7K ﹤0.01% 1752
2022
Q1
$3.18M Buy
38,691
+2,353
+6% +$193K ﹤0.01% 1775
2021
Q4
$5.33M Sell
36,338
-1,063
-3% -$156K ﹤0.01% 1535
2021
Q3
$6.62M Buy
37,401
+8,306
+29% +$1.47M ﹤0.01% 1394
2021
Q2
$4.7M Buy
29,095
+1,608
+6% +$260K ﹤0.01% 1564
2021
Q1
$4.71M Sell
27,487
-514
-2% -$88.1K ﹤0.01% 1583
2020
Q4
$6.15M Buy
28,001
+5,278
+23% +$1.16M ﹤0.01% 1364
2020
Q3
$3.77M Sell
22,723
-5
-0% -$830 ﹤0.01% 1486
2020
Q2
$2.6M Buy
22,728
+1,278
+6% +$146K ﹤0.01% 1620
2020
Q1
$1.65M Buy
21,450
+3,920
+22% +$301K ﹤0.01% 1664
2019
Q4
$2.26M Buy
17,530
+1,067
+6% +$137K ﹤0.01% 1744
2019
Q3
$1.28M Buy
16,463
+11,370
+223% +$886K ﹤0.01% 1894
2019
Q2
$525K Buy
5,093
+1,004
+25% +$103K ﹤0.01% 2134
2019
Q1
$299K Buy
4,089
+454
+12% +$33.2K ﹤0.01% 2251
2018
Q4
$154K Buy
3,635
+515
+17% +$21.8K ﹤0.01% 2362
2018
Q3
$147K Buy
3,120
+78
+3% +$3.68K ﹤0.01% 2401
2018
Q2
$150K Buy
+3,042
New +$150K ﹤0.01% 2365
2017
Q2
Sell
-3,790
Closed -$19K 3395
2017
Q1
$19K Hold
3,790
﹤0.01% 3094
2016
Q4
$18K Buy
3,790
+1,560
+70% +$7.41K ﹤0.01% 3138
2016
Q3
$15K Hold
2,230
﹤0.01% 2834
2016
Q2
$12K Hold
2,230
﹤0.01% 2881
2016
Q1
$48K Hold
2,230
﹤0.01% 2433
2015
Q4
$69K Buy
+2,230
New +$69K ﹤0.01% 2286